Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.03

-0.4%

2:51 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kenhott who wrote (31343)	5/30/2009 12:20:21 AM
From: Jon Khymn	Read Replies (3) of 52153

Thanks Ken for your well thought out reasons... Perhaps I should reduce my SVNT position and cover short positions further next week. I'm glad I asked you guys about SVNT. (This is my first Biotec option lured by juicy premium) Just came to Vegas, but the blackjack here isn't so exciting anymore after SVNT gambling :0) I guess it is 50/50 chance with SVNT. I'm guessing about 55/45 of passing chance this time, what is your gut feeling? (But I heard 8 patients died during the trial, that's kinda scary, no?) By the way, I been watching CYTK, EXEL and you seem to be following these stocks as well... No positions yet but I like EXEL, looks promising.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next